Clinical features and survival outcomes of 16 EBV-positive elderly DLBCL patients.

M, male; F, female; LN, lymph node; IPI, International Prognostic Index; R, Rituximab; CHOP, cyclophosphamide, doxorubicin(may be substituted by epirubicin or peglyated liposome doxorubicin), vincristine,prednisone; EPOCH, etoposide, cyclophosphamide, doxorubicin, vincristine, prednisone; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; AWD, alive with disease; AND, alive with no evidence of disease; DOD, died of disease. Clinical features and survival outcomes of 16 EBV-positive elderly DLBCL patients.